OPUS GENETICS INC (IRD) — insider trading
Health Care · NASDAQ
OPUS GENETICS INC (IRD) has 25 reported SEC Form 4 insider transactions in our data, including 13 open-market sales among the most recent 25 (latest 2026-09-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Foundation Fighting Blindness Retinal Degeneration Fund; Foundation Fighting Blindness, Inc. | Director, Other | Open-market sale | 556,000 | $4.96 | $2.76M | Form 4 |
| 2026-09-09 | Magrath George | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 392,157 | — | $0 | Form 4 |
| 2026-09-09 | Magrath George | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 75,541 | $5.97 | $451.0K | Form 4 |
| 2026-09-09 | Magrath George | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 392,157 | $1.15 | $451.0K | Form 4 |
| 2026-09-08 | Gallagher Cam | Director | Option exercise / conversion (derivative) | 784,314 | — | $0 | Form 4 |
| 2026-09-08 | Gallagher Cam | Director | Option exercise / conversion | 784,314 | $1.15 | $902.0K | Form 4 |
| 2026-09-03 | Gagnon Robert E. | Officer (Chief Financial Officer) | Open-market sale | 28,000 | $4.54 | $127.2K | Form 4 |
| 2026-07-23 | Gagnon Robert E. | Officer (Chief Financial Officer) | Open-market sale | 7,783 | $2.95 | $22.9K | Form 4 |
| 2026-07-23 | Magrath George | Director, Officer (Chief Executive Officer) | Open-market sale | 9,475 | $2.95 | $27.9K | Form 4 |
| 2026-07-23 | SCHACHLE JOSEPH K | Officer (Chief Operating Officer) | Open-market sale | 4,644 | $2.94 | $13.7K | Form 4 |
| 2026-07-23 | YERXA BENJAMIN R | Director, Officer (President) | Open-market sale | 7,429 | $2.97 | $22.1K | Form 4 |
| 2026-05-18 | Foundation Fighting Blindness Retinal Degeneration Fund; Foundation Fighting Blindness, Inc. | Director, Other | Open-market sale | 1,700,000 | $4.35 | $7.39M | Form 4 |
| 2026-04-23 | Gagnon Robert E. | Officer (Chief Financial Officer) | Open-market sale | 7,842 | $5.18 | $40.7K | Form 4 |
| 2026-04-23 | Jayagopal Ashwath | Officer (Chief Scientific & Dev. Ofc.) | Open-market sale | 7,542 | $5.19 | $39.2K | Form 4 |
| 2026-04-23 | Magrath George | Director, Officer (Chief Executive Officer) | Open-market sale | 9,511 | $5.22 | $49.6K | Form 4 |
| 2026-04-23 | Zaremba Rabourn Amy | Officer (Head of Fin. Quality Assurance) | Open-market sale | 1,641 | $5.20 | $8.5K | Form 4 |
| 2026-04-23 | SCHACHLE JOSEPH K | Officer (Chief Operating Officer) | Open-market sale | 4,697 | $5.22 | $24.5K | Form 4 |
| 2026-04-23 | YERXA BENJAMIN R | Director, Officer (President) | Open-market sale | 7,470 | $5.24 | $39.1K | Form 4 |
| 2026-04-20 | Ainsworth Sean | Director | Grant / award / vesting | 24,367 | — | $0 | Form 4 |
| 2026-04-20 | Bennett Jean | Director | Grant / award / vesting | 24,367 | — | $0 | Form 4 |
| 2026-04-20 | Benton Susan | Director | Grant / award / vesting | 24,367 | — | $0 | Form 4 |
| 2026-04-20 | Gallagher Cam | Director | Grant / award / vesting | 24,367 | — | $0 | Form 4 |
| 2026-04-20 | Graves Adrienne L | Director | Grant / award / vesting | 24,367 | — | $0 | Form 4 |
| 2026-04-20 | MANUSO JAMES S J | Director | Grant / award / vesting | 24,367 | — | $0 | Form 4 |
| 2026-04-20 | Rodgers Richard J | Director | Grant / award / vesting | 24,367 | — | $0 | Form 4 |
Ask the chat about IRD's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: OPUS GENETICS INC (IRD).
Last updated 2026-09-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.